Antiplatelet Therapy for Reduction of Myocardial Damage During Angioplasty-4 RELOAD - ARMYDA-4 RELOAD

Description:

The goal of this trial was to evaluate the safety and efficacy of clopidogrel 600 mg prior to percutaneous coronary intervention (PCI) compared with placebo among patients on chronic clopidogrel therapy.